United States Nuclear Receptor ROR-Gamma Market Report 2018

Publisher Name :
Date: 08-Mar-2018
No. of pages: 105
Inquire Before Buying

In this report, the United States Nuclear Receptor ROR-Gamma market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Nuclear Receptor ROR-Gamma in these regions, from 2013 to 2025 (forecast).

United States Nuclear Receptor ROR-Gamma market competition by top manufacturers/players, with Nuclear Receptor ROR-Gamma sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- 4SC AG

- Advinus Therapeutics Ltd.

- Arrien Pharmaceuticals, LLC

- Aurigene Discovery Technologies Limited

- Biogen, Inc.

- Brickell Biotech, Inc.

- Bristol-Myers Squibb Company

- Celgene Corporation

- Genentech, Inc.

- Genfit SA

- GlaxoSmithKline Plc

- Hanmi Pharmaceuticals, Co. Ltd.

- Karo Bio AB

- Lead Pharma Holding B.V.

- Nuevolution AB

- Phenex Pharmaceuticals AG

- Reata Pharmaceuticals, Inc.

- Teijin Pharma Limited

- Visionary Pharmaceuticals, Inc.

- Vitae Pharmaceuticals, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- VPR-66

- INV-17

- GSK-2981278

- BBI-6000

- Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Hospital

- Clinic

- Others

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Nuclear Receptor ROR-Gamma Market Report 2018

Table of Contents
United States Nuclear Receptor ROR-Gamma Market Report 2018
1 Nuclear Receptor ROR-Gamma Overview
1.1 Product Overview and Scope of Nuclear Receptor ROR-Gamma
1.2 Classification of Nuclear Receptor ROR-Gamma by Product Category
1.2.1 United States Nuclear Receptor ROR-Gamma Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Nuclear Receptor ROR-Gamma Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 VPR-66
1.2.4 INV-17
1.2.5 GSK-2981278
1.2.6 BBI-6000
1.2.7 Others
1.3 United States Nuclear Receptor ROR-Gamma Market by Application/End Users
1.3.1 United States Nuclear Receptor ROR-Gamma Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 United States Nuclear Receptor ROR-Gamma Market by Region
1.4.1 United States Nuclear Receptor ROR-Gamma Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Nuclear Receptor ROR-Gamma Status and Prospect (2013-2025)
1.4.3 Southwest Nuclear Receptor ROR-Gamma Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Nuclear Receptor ROR-Gamma Status and Prospect (2013-2025)
1.4.5 New England Nuclear Receptor ROR-Gamma Status and Prospect (2013-2025)
1.4.6 The South Nuclear Receptor ROR-Gamma Status and Prospect (2013-2025)
1.4.7 The Midwest Nuclear Receptor ROR-Gamma Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Nuclear Receptor ROR-Gamma (2013-2025)
1.5.1 United States Nuclear Receptor ROR-Gamma Sales and Growth Rate (2013-2025)
1.5.2 United States Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2013-2025)
2 United States Nuclear Receptor ROR-Gamma Market Competition by Players/Suppliers
2.1 United States Nuclear Receptor ROR-Gamma Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Nuclear Receptor ROR-Gamma Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Nuclear Receptor ROR-Gamma Average Price by Players/Suppliers (2013-2018)
2.4 United States Nuclear Receptor ROR-Gamma Market Competitive Situation and Trends
2.4.1 United States Nuclear Receptor ROR-Gamma Market Concentration Rate
2.4.2 United States Nuclear Receptor ROR-Gamma Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Nuclear Receptor ROR-Gamma Manufacturing Base Distribution, Sales Area, Product Type
3 United States Nuclear Receptor ROR-Gamma Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Nuclear Receptor ROR-Gamma Sales and Market Share by Region (2013-2018)
3.2 United States Nuclear Receptor ROR-Gamma Revenue and Market Share by Region (2013-2018)
3.3 United States Nuclear Receptor ROR-Gamma Price by Region (2013-2018)
4 United States Nuclear Receptor ROR-Gamma Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Nuclear Receptor ROR-Gamma Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Nuclear Receptor ROR-Gamma Revenue and Market Share by Type (2013-2018)
4.3 United States Nuclear Receptor ROR-Gamma Price by Type (2013-2018)
4.4 United States Nuclear Receptor ROR-Gamma Sales Growth Rate by Type (2013-2018)
5 United States Nuclear Receptor ROR-Gamma Sales (Volume) by Application (2013-2018)
5.1 United States Nuclear Receptor ROR-Gamma Sales and Market Share by Application (2013-2018)
5.2 United States Nuclear Receptor ROR-Gamma Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Nuclear Receptor ROR-Gamma Players/Suppliers Profiles and Sales Data
6.1 4SC AG
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 4SC AG Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Advinus Therapeutics Ltd.
6.2.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Arrien Pharmaceuticals, LLC
6.3.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Aurigene Discovery Technologies Limited
6.4.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Biogen, Inc.
6.5.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Brickell Biotech, Inc.
6.6.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Bristol-Myers Squibb Company
6.7.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Celgene Corporation
6.8.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Genentech, Inc.
6.9.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Genfit SA
6.10.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Genfit SA Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 GlaxoSmithKline Plc
6.12 Hanmi Pharmaceuticals, Co. Ltd.
6.13 Karo Bio AB
6.14 Lead Pharma Holding B.V.
6.15 Nuevolution AB
6.16 Phenex Pharmaceuticals AG
6.17 Reata Pharmaceuticals, Inc.
6.18 Teijin Pharma Limited
6.19 Visionary Pharmaceuticals, Inc.
6.20 Vitae Pharmaceuticals, Inc.
7 Nuclear Receptor ROR-Gamma Manufacturing Cost Analysis
7.1 Nuclear Receptor ROR-Gamma Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nuclear Receptor ROR-Gamma
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Nuclear Receptor ROR-Gamma Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nuclear Receptor ROR-Gamma Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Nuclear Receptor ROR-Gamma Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Nuclear Receptor ROR-Gamma Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Nuclear Receptor ROR-Gamma Sales Volume Forecast by Type (2018-2025)
11.3 United States Nuclear Receptor ROR-Gamma Sales Volume Forecast by Application (2018-2025)
11.4 United States Nuclear Receptor ROR-Gamma Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Nuclear Receptor ROR-Gamma
Figure United States Nuclear Receptor ROR-Gamma Market Size (K Pcs) by Type (2013-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume Market Share by Type (Product Category) in 2017
Figure VPR-66 Product Picture
Figure INV-17 Product Picture
Figure GSK-2981278 Product Picture
Figure BBI-6000 Product Picture
Figure Others Product Picture
Figure United States Nuclear Receptor ROR-Gamma Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Nuclear Receptor ROR-Gamma by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Nuclear Receptor ROR-Gamma Market Size (Million USD) by Region (2013-2025)
Figure The West Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Nuclear Receptor ROR-Gamma Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Nuclear Receptor ROR-Gamma Sales Share by Players/Suppliers
Figure 2017 United States Nuclear Receptor ROR-Gamma Sales Share by Players/Suppliers
Figure United States Nuclear Receptor ROR-Gamma Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Nuclear Receptor ROR-Gamma Revenue Share by Players/Suppliers
Figure 2017 United States Nuclear Receptor ROR-Gamma Revenue Share by Players/Suppliers
Table United States Market Nuclear Receptor ROR-Gamma Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Nuclear Receptor ROR-Gamma Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Nuclear Receptor ROR-Gamma Market Share of Top 3 Players/Suppliers
Figure United States Nuclear Receptor ROR-Gamma Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Nuclear Receptor ROR-Gamma Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Nuclear Receptor ROR-Gamma Product Category
Table United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Region (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales Share by Region (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Share by Region (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Market Share by Region in 2017
Table United States Nuclear Receptor ROR-Gamma Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Revenue Share by Region (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Revenue Market Share by Region (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Revenue Market Share by Region in 2017
Table United States Nuclear Receptor ROR-Gamma Price (USD/Pcs) by Region (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Type (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales Share by Type (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Share by Type (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Market Share by Type in 2017
Table United States Nuclear Receptor ROR-Gamma Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Nuclear Receptor ROR-Gamma by Type (2013-2018)
Figure Revenue Market Share of Nuclear Receptor ROR-Gamma by Type in 2017
Table United States Nuclear Receptor ROR-Gamma Price (USD/Pcs) by Types (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Growth Rate by Type (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Application (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales Market Share by Application (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Market Share by Application (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Market Share by Application in 2017
Table United States Nuclear Receptor ROR-Gamma Sales Growth Rate by Application (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Growth Rate by Application (2013-2018)
Table 4SC AG Basic Information List
Table 4SC AG Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure 4SC AG Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure 4SC AG Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure 4SC AG Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Advinus Therapeutics Ltd. Basic Information List
Table Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Arrien Pharmaceuticals, LLC Basic Information List
Table Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Aurigene Discovery Technologies Limited Basic Information List
Table Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Biogen, Inc. Basic Information List
Table Biogen, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Biogen, Inc. Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Biogen, Inc. Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Brickell Biotech, Inc. Basic Information List
Table Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Celgene Corporation Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Celgene Corporation Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Celgene Corporation Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Genentech, Inc. Basic Information List
Table Genentech, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genentech, Inc. Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Genentech, Inc. Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Genfit SA Basic Information List
Table Genfit SA Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genfit SA Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Genfit SA Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Genfit SA Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Plc Basic Information List
Table Hanmi Pharmaceuticals, Co. Ltd. Basic Information List
Table Karo Bio AB Basic Information List
Table Lead Pharma Holding B.V. Basic Information List
Table Nuevolution AB Basic Information List
Table Phenex Pharmaceuticals AG Basic Information List
Table Reata Pharmaceuticals, Inc. Basic Information List
Table Teijin Pharma Limited Basic Information List
Table Visionary Pharmaceuticals, Inc. Basic Information List
Table Vitae Pharmaceuticals, Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Receptor ROR-Gamma
Figure Manufacturing Process Analysis of Nuclear Receptor ROR-Gamma
Figure Nuclear Receptor ROR-Gamma Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Receptor ROR-Gamma Major Players/Suppliers in 2017
Table Major Buyers of Nuclear Receptor ROR-Gamma
Table Distributors/Traders List
Figure United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Nuclear Receptor ROR-Gamma Sales Volume Share Forecast by Region (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume Share Forecast by Region (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Microcarrier Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 120
    A microcarrier is a support matrix allowing for the growth of adherent cells in bioreactors. Scope of the Report: This report focuses on the Microcarrier in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. In 2017, Europe dominated the global microcarriers market. Growth in this market can mainly be attributed to factors......
  • Global Sexual Wellness Products Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 136
    Sexual wellness refers to the physical, mental, and sexual well-being of people. Products such as erotic lingerie, condoms and contraceptives, personal lubricants, sex toys, and others such as testing cards and pregnancy testing kits, sexual enhancement supplements, sex games, and vaginal sexual wellness products, which enhance safety and pleasure of sexual experiences, are considered sexual wellness products. Scope of the Report: This report focuses on the Sexual Wellness ......
  • Global Labyrinthitis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 118
    Labyrinthitis, also known as vestibular neuritis, is an inflammation of the inner earor the nerves that connect the inner ear to the brain due to a variety of reasons such as infection by measles, mumps, trauma, autoimmune etc. Scope of the Report: This report focuses on the Labyrinthitis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and ......
  • Global Latex Allergy Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 122
    Latex allergy is caused by exposure to substances made of latex (natural rubber). The exposure leads to a person's immune system reaction to harmless protein in such a way as if the proteins are antigens, or disease causing. Antibodies and antihistamines get released in the body as result so as to react to the natural harmless proteins which may cause symptoms such as itchy hands, skin rash, hives, and eczema (cracking of skin). It is commonly caused in people who are exposed to latex based prod......
  • Global Atopic Dermatitis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 122
    Atopic dermatitis (AD) is a pruritic disease of unknown origin that usually starts in early infancy (an adult-onset variant is recognized). Scope of the Report: This report focuses on the Atopic Dermatitis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. One of the major factors responsible for the growing risk ......
  • Global Asthma Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 122
    Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors. Scope of the Report: This report focuses on the Asthma Drugs in global market, especially in......
  • Global Over the Counter (OTC) Drugs & Dietary Supplements Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 136
    Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements. Scope of the Report:......
  • Global Over The Counter (OTC) Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 119
    Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Scope of the Report: This report focuses on the Over The Counter (OTC) Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, re......
  • Global Oseltamivir Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 102
    Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B (flu). Scope of the Report: This report focuses on the Oseltamivir in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for Oseltamivir is expected to grow at a CAGR of roug......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs